We are pleased to announce that Malignancy Spectrum has received an official notification from Scopus confirming that the journal has been accepted for inclusion in the Scopus database. The journal is expected to be formally indexed following the completion of the relevant database processing and updating procedures.

This achievement represents an important milestone in the development of Malignancy Spectrum and reflects the journal’s continued commitment to high-quality scholarly publishing, rigorous peer review, editorial standards, and international engagement.

Published by Higher Education Press, Malignancy Spectrum is an international, open-access, peer-reviewed journal dedicated to high-quality research across the spectrum of cancer science and medicine. Malignancy Spectrum publishes quality and impactful work spanning areas ranging from epidemiology to immunotherapy for the treatment of metastatic disease, and provides a platform dedicated to work focusing on novel emerging areas of cancer research, including but not limited to aging and cancer, geriatric oncology, and palliative care.

Scopus is one of the world's major abstract and citation databases, with journal selection conducted through a rigorous content selection and quality assessment process.

We sincerely thank our authors, reviewers, Editorial Board Members, and readers for their continued support and confidence in Malignancy Spectrum.

Moving forward, Malignancy Spectrum will continue to uphold high standards of academic quality and editorial integrity, strengthen its international visibility, and provide a trusted platform for the dissemination and exchange of high-quality research in oncology.